138 related articles for article (PubMed ID: 8582181)
1. [A study on serum soluble interleukin-2 receptor level in the diagnosis of acute rejection in renal transplantation].
Lu J; Tian J; Zhang J
Zhonghua Nei Ke Za Zhi; 1995 Jun; 34(6):371-3. PubMed ID: 8582181
[TBL] [Abstract][Full Text] [Related]
2. Serum interleukin-2 and soluble interleukin-2 receptor in renal transplant recipients.
Lee PH; Chung YC; Hu RH; Huang MT; Chao SH; Lee CJ; Lee CS
J Formos Med Assoc; 1992 Sep; 91(9):844-8. PubMed ID: 1363382
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin 2 receptor (sIL-2R) levels in renal transplant recipients.
Mehta R; Shah G; Adler W; Kittur D
Clin Transplant; 2004; 18 Suppl 12():67-71. PubMed ID: 15217411
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-2 receptor (sIL-2R) levels in renal transplantation: comparison between clinical and laboratory analysis.
Montagnino G; Tarantino A; Grignani S; Braga M; Ponticelli C
Clin Transplant; 1995 Feb; 9(1):25-30. PubMed ID: 7742579
[TBL] [Abstract][Full Text] [Related]
5. Serum & urinary interleukin-2 levels as predictors in acute renal allograft rejection.
Gupta RK; Jain M; Sharma RK
Indian J Med Res; 2004 Jan; 119(1):24-7. PubMed ID: 14997990
[TBL] [Abstract][Full Text] [Related]
6. A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipients.
Schroeder TJ; Helling T; McKenna RM; Rush D; Jeffrey JR; Brewer B; Martin LA; Traylor D; Fisher RA; First MR
Transplantation; 1992 Jan; 53(1):34-40. PubMed ID: 1733082
[TBL] [Abstract][Full Text] [Related]
7. Sequential monitoring of urine-soluble interleukin 2 receptor and interleukin 6 predicts acute rejection of human renal allografts before clinical or laboratory signs of renal dysfunction.
Casiraghi F; Ruggenenti P; Noris M; Locatelli G; Perico N; Perna A; Remuzzi G
Transplantation; 1997 May; 63(10):1508-14. PubMed ID: 9175818
[TBL] [Abstract][Full Text] [Related]
8. Serum soluble interleukin 2 receptor (sIL-2R) as a marker of acute rejection in renal transplant children.
García-Roca P; Vargas YA; Fuentes Y; Hernández AM; Ortiz L; Valverde S; Velásquez-Jones L; Romero-Navarro B; Ramón-Garcia G; Medeiros M
Pediatr Transplant; 2012 May; 16(3):274-9. PubMed ID: 22309031
[TBL] [Abstract][Full Text] [Related]
9. Increased circulating concentrations of interleukin 2 receptor during rejection episodes in heart- or kidney-transplant recipients.
Zucchelli GC; Clerico A; De Maria R; Carmellini M; Di Stefano R; Masini S; Pilo A; Donato L
Clin Chem; 1990 Dec; 36(12):2106-9. PubMed ID: 2253354
[TBL] [Abstract][Full Text] [Related]
10. Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease.
Miyamoto T; Akashi K; Hayashi S; Gondo H; Murakawa M; Tanimoto K; Harada M; Niho Y
Bone Marrow Transplant; 1996 Feb; 17(2):185-90. PubMed ID: 8640164
[TBL] [Abstract][Full Text] [Related]
11. An assessment of serum and urine soluble interleukin-2 receptor concentrations during renal transplant rejection.
Bock GH; Neu L; Long C; Patterson LT; Korb S; Gelpi J; Nelson DL
Am J Kidney Dis; 1994 Mar; 23(3):421-6. PubMed ID: 8128944
[TBL] [Abstract][Full Text] [Related]
12. Inability of isolated soluble interleukin-2 receptor levels to predict biopsy rejection scores after heart transplantation.
Young JB; Windsor NT; Smart FW; Kleiman NS; Weilbaecher DG; Noon GP; Nelson DL; Lawrence EC
Transplantation; 1991 Mar; 51(3):636-41. PubMed ID: 2006520
[TBL] [Abstract][Full Text] [Related]
13. Association of high pretransplant sIL-6R plasma levels with acute tubular necrosis in kidney graft recipients.
Sadeghi M; Daniel V; Naujokat C; Mehrabi A; Opelz G
Transplantation; 2006 Jun; 81(12):1716-24. PubMed ID: 16794539
[TBL] [Abstract][Full Text] [Related]
14. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
Tang Z; Zhang J; Zhang S; Li L
Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
[TBL] [Abstract][Full Text] [Related]
16. [Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery].
Tsukamoto S; Ishikawa S; Yamauchi A; Saitou S
Hinyokika Kiyo; 2000 Oct; 46(10):695-9. PubMed ID: 11215193
[TBL] [Abstract][Full Text] [Related]
17. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME
Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
Remberger M; Ringdén O
Transplantation; 1995 Dec; 60(11):1293-9. PubMed ID: 8525524
[TBL] [Abstract][Full Text] [Related]
19. [The level of soluble interleukin 2 receptor in esophageal carcinoma patients before and after radiotherapy].
Liu X; An H; Jiang Y
Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):97-9. PubMed ID: 7656815
[TBL] [Abstract][Full Text] [Related]
20. [Dynamic monitoring of sIL-2R, IL-2 and IL-6 levels of serum after double-hand transplantation].
Xiang D; Pei G; Qiu Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2004 May; 18(3):232-5. PubMed ID: 15211844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]